At the in vivo level, it has been shown that young (20–30 days) heterozygous mice with a Sip1 mutation in the cerebral cortex, which were administered pilocarpine, exhibit mild signs of epilepsy and survive the experiments [8]. This evidence concerns the gene ZEB2 and epilepsy.